No Picture
News

Graphite Bio begins SCD cell therapy trial; Synthetic Biologics’ future rests on VCN acquisition

Graphite Bio has dosed its first sickle cell disease patient with its cell therapy, the Bay Area biotech announced this morning. In its proof-of-concept CEDAR trial, the biotech plans to enroll 15 patients and share early data mid-2023. Graphite joins … […]

No Picture
News

IDIBAPS Researchers Discover Genetic Drivers of Clonal Evolution in Leukemia Using Single-Cell DNA Sequencing from Mission Bio

Tapestri® Platform powers Nature Medicine publication that identified rare subclones associated with aggressive cancer progression SOUTH SAN FRANCISCO, Calif., Aug. 11, 2022 /PRNewswire/ — Mission Bio, the pioneer in high-throughput single-cell DNA an… […]

No Picture
News

Gene Therapy Market to be Worth $10.0 Billion by 2028 with CAGR of 20.4%: Grand View Research, Inc.

SAN FRANCISCO, Aug. 11, 2022 /PRNewswire/ — The global gene therapy market size is expected to reach USD 10.0 billion by 2028 registering a CAGR of 20.4% during the forecast period, according to a new report by Grand View Research, Inc. The market gro… […]

No Picture
News

STAT+: Pharmalittle: Judge rules Walgreens helped fuel San Francisco opioid crisis; U.S. plan to bottle monkeypox vaccine could take months

A U.S. federal judge ruled that Walgreens helped fuel the opioid epidemic in San Francisco by shipping thousands of “suspicious orders” of prescription drugs to its pharmacies. […]

No Picture
News

Ellipsis Health and Ceras Health Partner to Improve Early Detection of Mental Health Conditions Using Voice Biomarker Technology

Partnership will integrate Ellipsis Health’s clinical grade mental health assessment technology into Ceras Health’s clinical monitoring platform to improve assessment and care SAN FRANCISCO, Aug. 11, 2022 /PRNewswire/ — Ellipsis Health, the market lea… […]

No Picture
News

AcelRx Pharmaceuticals Announces Abstract Acceptance for Podium Presentation at Plastic Surgery: The Meeting 2022

HAYWARD, Calif., Aug. 11, 2022 /PRNewswire/ — AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, … […]

No Picture
News

Covalent Metrology Offers Nuclear Magnetic Resonance (NMR) Services with New Spectrometer from JEOL

The installation of the JEOL JNM-ECZL-500 NMR Spectrometer enables Covalent to support clients with faster and more flexible NMR analysis SUNNYVALE, Calif., Aug. 11, 2022 /PRNewswire/ — Covalent Metrology, a leading North-American provider of analytic… […]